http://ift.tt/eA8V8J The Botox maker has rejected a $53 billion joint offer from Ackman and Canadian drugmaker Valeant Pharmaceuticals International. Allergan said in April that its board had adopted a one-year shareholder rights plan to give it more time to consider takeover proposals. Allergan's shareholder rights plan will trigger if a person or group acquires 10 percent or more of its shares. The lawsuit filed in Delaware Court of Chancery followed a request to Allergan from Pershing Square on June 6 seeking confirmation that Allergan would not use its poison pill to impede Ackman's request for a special meeting.
from Yahoo! Finance: Top Stories http://ift.tt/1kuX4Co
via IFTTT
from Yahoo! Finance: Top Stories http://ift.tt/1kuX4Co
via IFTTT
No comments:
Post a Comment